These results suggest that senescent CD4+ T lymphocytes acquire a pro-inflammatory and pro-osteolytic phenotype, potentially contributing to inflammatory and bone-resorptive diseases, which warrants further investigation. This evidence concerns the gene CD4 and bone resorption disease.